Market Tracker

08/18 5:16pm ET

Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.4068
Delayed Data
As of Aug 18
 -0.0008 / -0.20%
Today’s Change
0.26
Today|||52-Week Range
1.16
-36.19%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.41
Today’s open0.40
Day’s range0.40 - 0.41
Volume100,267
Average volume (3 months)366,182
Market cap$66.0M
Dividend yield--
Data as of 7:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)+111.11%
Earnings growth (next 5 years)--
Revenue growth (last year)+65.82%
P/E ratioNM
Price/Sales4.51
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EIGREiger BioPharmaceuti...+0.05+0.64%
ATXIAvenue Therapeutics ...-0.13-1.95%
NOVNNovan Inc-0.08-1.97%
FLKSFlex Pharma Inc-0.10-2.78%
Data as of 4:00pm ET, 08/18/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$22.0M
Annual profit (last year)-$14.3M
Net profit margin-65.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
CFO, COO, Secretary &
Treasurer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts